Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. lifted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 668.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,021,636 shares of the pharmacy operator's stock after acquiring an additional 888,710 shares during the quarter. Rockefeller Capital Management L.P. owned about 0.12% of Walgreens Boots Alliance worth $9,534,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in WBA. Vanguard Group Inc. boosted its stake in shares of Walgreens Boots Alliance by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after purchasing an additional 2,279,495 shares during the period. Invesco Ltd. boosted its position in Walgreens Boots Alliance by 8.8% in the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock valued at $303,902,000 after buying an additional 2,631,332 shares during the last quarter. Geode Capital Management LLC boosted its position in Walgreens Boots Alliance by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock valued at $194,082,000 after buying an additional 1,020,587 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Walgreens Boots Alliance by 19.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock valued at $122,737,000 after acquiring an additional 2,185,950 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $58,241,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Performance

Shares of Walgreens Boots Alliance stock traded up $0.12 on Tuesday, reaching $10.99. 10,775,459 shares of the company were exchanged, compared to its average volume of 21,036,217. The firm has a market cap of $9.50 billion, a price-to-earnings ratio of -1.07, a P/E/G ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $18.83. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company's 50-day moving average is $10.90 and its two-hundred day moving average is $10.17.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. During the same period last year, the company earned $1.20 earnings per share. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on WBA shares. Evercore ISI raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price target for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. StockNews.com began coverage on shares of Walgreens Boots Alliance in a report on Saturday. They issued a "hold" rating on the stock. Truist Financial decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Finally, Bank of America upped their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research note on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.